Literature DB >> 24635550

What happens in treatment doesn't stay in treatment: cocaine abstinence during treatment is associated with fewer problems at follow-up.

Brian D Kiluk1, Charla Nich1, Katie Witkiewitz2, Theresa A Babuscio1, Kathleen M Carroll1.   

Abstract

OBJECTIVE: Cocaine users often present to treatment with a multitude of problems typically considered addiction related; however, there is little evidence that reductions in cocaine use are followed by reductions in these problems. This study evaluated the relationship between rates of cocaine use during treatment and the level of non-cocaine life problems experienced during a 12-month period following treatment in a pooled sample of 434 cocaine-dependent individuals participating in 1 of 5 randomized controlled trials.
METHOD: Structural equation modeling and latent growth curve modeling were used to evaluate the relationship between frequency of cocaine use within treatment (8 or 12 weeks) and a latent construct of global problems indicated by the days of problems reported on the Addiction Severity Index across follow-up time points (1, 3, 6, and 12 months after treatment).
RESULTS: Both a continuous latent cocaine use outcome measure (percent days abstinent, percent positive urines, and maximum days of consecutive abstinence) and a dichotomous measure of cocaine use (≥21 consecutive days of abstinence) during the treatment period were associated with frequency of cocaine use and global problems during follow-up. Overall, results indicated that greater cocaine abstinence during the treatment period was associated with higher rates of abstinence and fewer global problems experienced following treatment.
CONCLUSION: This is one of the first studies to support a model that suggests addiction-related problems decrease in accordance with achieving abstinence from cocaine, thereby providing evidence that within-treatment cocaine abstinence has benefits that extend beyond the frequency of drug use. PsycINFO Database Record (c) 2014 APA, all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24635550      PMCID: PMC4115028          DOI: 10.1037/a0036245

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  41 in total

1.  The antecedents and benefits of achieving abstinence in opioid addicts: a 2.5-year follow-up study.

Authors:  B J Rounsaville; T R Kosten; H D Kleber
Journal:  Am J Drug Alcohol Abuse       Date:  1987       Impact factor: 3.829

2.  Antecedents and consequences of cocaine abuse among opioid addicts. A 2.5-year follow-up.

Authors:  T R Kosten; B J Rounsaville; H D Kleber
Journal:  J Nerv Ment Dis       Date:  1988-03       Impact factor: 2.254

3.  Interviewer severity ratings and composite scores of the ASI: a further look.

Authors:  A I Alterman; L S Brown; A Zaballero; J R McKay
Journal:  Drug Alcohol Depend       Date:  1994-02       Impact factor: 4.492

Review 4.  Toward empirical identification of a clinically meaningful indicator of treatment outcome: features of candidate indicators and evaluation of sensitivity to treatment effects and relationship to one year follow up cocaine use outcomes.

Authors:  Kathleen M Carroll; Brian D Kiluk; Charla Nich; Elise E DeVito; Suzanne Decker; Donna LaPaglia; Dianne Duffey; Theresa A Babuscio; Samuel A Ball
Journal:  Drug Alcohol Depend       Date:  2014-01-31       Impact factor: 4.492

5.  The Fifth Edition of the Addiction Severity Index.

Authors:  A T McLellan; H Kushner; D Metzger; R Peters; I Smith; G Grissom; H Pettinati; M Argeriou
Journal:  J Subst Abuse Treat       Date:  1992

6.  Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram.

Authors:  K M Carroll; C Nich; S A Ball; E McCance; B J Rounsavile
Journal:  Addiction       Date:  1998-05       Impact factor: 6.526

7.  Predicting response to alcohol and drug abuse treatments. Role of psychiatric severity.

Authors:  A T McLellan; L Luborsky; G E Woody; C P O'Brien; K A Druley
Journal:  Arch Gen Psychiatry       Date:  1983-06

8.  Psychotherapy and pharmacotherapy for ambulatory cocaine abusers.

Authors:  K M Carroll; B J Rounsaville; L T Gordon; C Nich; P Jatlow; R M Bisighini; F H Gawin
Journal:  Arch Gen Psychiatry       Date:  1994-03

9.  Problems in the application of the Addiction Severity Index (ASI) in rural substance abuse services.

Authors:  J S Wertz; B L Cleaveland; R S Stephens
Journal:  J Subst Abuse       Date:  1995

10.  Similarity of outcome predictors across opiate, cocaine, and alcohol treatments: role of treatment services.

Authors:  A T McLellan; A I Alterman; D S Metzger; G R Grissom; G E Woody; L Luborsky; C P O'Brien
Journal:  J Consult Clin Psychol       Date:  1994-12
View more
  14 in total

1.  Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder.

Authors:  Dustin C Lee; Nicolas J Schlienz; Erica N Peters; Robert H Dworkin; Dennis C Turk; Eric C Strain; Ryan Vandrey
Journal:  Drug Alcohol Depend       Date:  2018-11-15       Impact factor: 4.492

2.  Examining Risk for Frequent Cocaine Use: Focus on an African American Treatment Population.

Authors:  Tamika Chere Barkley Zapolski; Patrick Baldwin; Carl W Lejuez
Journal:  Subst Use Misuse       Date:  2016-04-21       Impact factor: 2.164

3.  Short and long-term improvements in psychiatric symptomatology to validate clinically meaningful treatment outcomes for cocaine use disorders.

Authors:  André Q C Miguel; Brian D Kiluk; Theresa A Babuscio; Charla Nich; Jair J Mari; Kathleen M Carroll
Journal:  Drug Alcohol Depend       Date:  2019-03-20       Impact factor: 4.492

4.  Randomized controlled trial of enhanced telephone monitoring with detoxification patients: 3- and 6-month outcomes.

Authors:  Christine Timko; Maureen Below; Lisa Vittorio; Emmeline Taylor; Grace Chang; Steven Lash; Fe Erlita D Festin; Deborah Brief
Journal:  J Subst Abuse Treat       Date:  2019-01-04

5.  What defines a clinically meaningful outcome in the treatment of substance use disorders: reductions in direct consequences of drug use or improvement in overall functioning?

Authors:  Brian D Kiluk; Garrett M Fitzmaurice; Eric C Strain; Roger D Weiss
Journal:  Addiction       Date:  2018-06-27       Impact factor: 6.526

Review 6.  Measures of outcome for stimulant trials: ACTTION recommendations and research agenda.

Authors:  Brian D Kiluk; Kathleen M Carroll; Amy Duhig; Daniel E Falk; Kyle Kampman; Shengan Lai; Raye Z Litten; David J McCann; Ivan D Montoya; Kenzie L Preston; Phil Skolnick; Constance Weisner; George Woody; Redonna Chandler; Michael J Detke; Kelly Dunn; Robert H Dworkin; Joanne Fertig; Jennifer Gewandter; F Gerard Moeller; Tatiana Ramey; Megan Ryan; Kenneth Silverman; Eric C Strain
Journal:  Drug Alcohol Depend       Date:  2015-11-21       Impact factor: 4.492

7.  Initial validation of a proxy indicator of functioning as a potential tool for establishing a clinically meaningful cocaine use outcome.

Authors:  Brian D Kiluk; Theresa A Babuscio; Charla Nich; Kathleen M Carroll
Journal:  Drug Alcohol Depend       Date:  2017-08-14       Impact factor: 4.492

8.  Smokers versus snorters: do treatment outcomes differ according to route of cocaine administration?

Authors:  Brian D Kiluk; Theresa A Babuscio; Charla Nich; Kathleen M Carroll
Journal:  Exp Clin Psychopharmacol       Date:  2013-12       Impact factor: 3.157

9.  Patterns of Cocaine Use During Treatment: Associations With Baseline Characteristics and Follow-Up Functioning.

Authors:  Corey R Roos; Charla Nich; Chung Jung Mun; Justin Mendonca; Theresa A Babuscio; Katie Witkiewitz; Kathleen M Carroll; Brian D Kiluk
Journal:  J Stud Alcohol Drugs       Date:  2019-07       Impact factor: 2.582

10.  Within-treatment frequency of use versus abstinence as a predictor of longitudinal post-treatment follow-up assessments of drug use.

Authors:  Garrett M Fitzmaurice; Stuart R Lipsitz; Roger D Weiss
Journal:  Drug Alcohol Depend       Date:  2020-01-17       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.